Co-founder of AI platform that improves ECG analysis named European Innovator of the Year
Cardiologs co-founder and CEO Yann Fleureau was named the European Innovator of the Year by MIT Technology Review, which also included the French native on its list of the top 35 European innovators under the age of 35. Cardiologs offers a cloud-based artificial intelligence (AI) platform that enables the detection of 14 cardiac arrhythmias through ambulatory electrocardiogram (ECG) readings.
“This technology not only improves cardiac diagnostic efficiency and analysis of ECGs, but also democratizes access to make expert cardiac diagnostics more available in developing countries and emerging markets,” Fleureau said in a press release. “I am proud of the work our team has done.”
According to the release, the platform is built on a database of more than 600,000 ECG recordings and is the first commercially available algorithm for analyzing ECGs using deep learning. It is approved in both Europe and the U.S. and is accessible from any digital device.
"With Cardiologs and their use of artificial intelligence in cardiac diagnostics, Yann Fleureau proposes a technological revolution in a tool that has been used in clinical practice for many years, but whose potential is now growing exponentially with the availability of new devices capable of recording ECGs,” the organizing team of Innovators Under 35 Europe said in the release. “With Cardiologs, we now have a scalable expert analysis solution that can help make sense of this new flow of valuable clinical information and can form a key building block in the medicine of the future."
In MIT Technology Review’s profile of Fleureau, the CEO said the smart ECGs could help nonspecialist clinicians in areas with limited healthcare resources correctly diagnose arrhythmias and conditions such as heart attack. He sees the technology eventually progressing from diagnosing diseases to predicting them, and said "the next step is to extend its reach, collect more data and continue improving the tool.”
Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.